These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4055706)

  • 41. Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine.
    Fernandez F; Levy JK; Samley HR; Pirozzolo FJ; Lachar D; Crowley J; Adams S; Ross B; Ruiz P
    Int J Psychiatry Med; 1995; 25(1):53-67. PubMed ID: 7649718
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Desipramine versus phenelzine in recurrent unipolar depression: clinical characteristics and treatment response.
    Swann AC; Bowden CL; Rush AJ; Rhoades H; Rose R; Kobes R
    J Clin Psychopharmacol; 1997 Apr; 17(2):78-83. PubMed ID: 10950467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin and depression. International Symposium on Tianeptine. Satellite of Symposium on Affect and Emotion, World Psychiatric Association. Vienna, Austria, October 10, 1987. Proceedings.
    Clin Neuropharmacol; 1988; 11 Suppl 2():S1-102. PubMed ID: 3180114
    [No Abstract]   [Full Text] [Related]  

  • 44. Tricyclic blood levels.
    Boyer WT
    Am J Psychiatry; 1985 Nov; 142(11):1388. PubMed ID: 4061701
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of tricyclic antidepressants in recipients of heart transplants.
    Kay J; Bienenfeld D; Slomowitz M; Burk J; Zimmer L; Nadolny G; Marvel NT; Geier P
    Psychosomatics; 1991; 32(2):165-70. PubMed ID: 2027938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of response to desipramine in dysthymia.
    Friedman RA; Parides M; Baff R; Moran M; Kocsis JH
    J Clin Psychopharmacol; 1995 Aug; 15(4):280-3. PubMed ID: 7593711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mood response to methylphenidate in depressed patients on zimelidine.
    Joyce PR
    J Clin Psychopharmacol; 1986 Oct; 6(5):317-8. PubMed ID: 2945837
    [No Abstract]   [Full Text] [Related]  

  • 48. Desipramine and methylphenidate combination treatment for depression: case report.
    Drimmer EJ; Gitlin MJ; Gwirtsman HE
    Am J Psychiatry; 1983 Feb; 140(2):241-2. PubMed ID: 6849446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Usefulness of desipramine in ICU cancer patients for acute depression.
    Thangathurai D; Roffey P; Mogos M; Riad M; Mikhail M
    J Palliat Care; 2004; 20(4):326. PubMed ID: 15690838
    [No Abstract]   [Full Text] [Related]  

  • 50. Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.
    Simpson GM; Pi EH; Abdelmalek E; Boyd JL; Carroll RS; Cooper TB; Miller A
    Psychopharmacology (Berl); 1983; 80(3):240-2. PubMed ID: 6412268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroleptic dose and desipramine concentrations during combined treatment of unipolar delusional depression.
    Nelson JC; Price LH; Jatlow PI
    Am J Psychiatry; 1986 Sep; 143(9):1151-4. PubMed ID: 3752299
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methylphenidate in treating poststroke depression.
    Lingam VR; Lazarus LW; Groves L; Oh SH
    J Clin Psychiatry; 1988 Apr; 49(4):151-3. PubMed ID: 3356672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Depression, antidepressants, and plasma DBH.
    Mathew RJ; Ho BT; Davis C; Taylor D; Reck J
    Psychiatry Res; 1981 Dec; 5(3):331-4. PubMed ID: 6948312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Behavioral effects of tricyclic drugs in depressed inpatients.
    Lyons JS; Rosen AJ; Dysken MW
    J Consult Clin Psychol; 1985 Feb; 53(1):17-24. PubMed ID: 3980824
    [No Abstract]   [Full Text] [Related]  

  • 55. Late onset tricyclic-induced agranulocytosis with an atypical course.
    Cabaniss DL; Roose SP
    Pharmacopsychiatry; 1993 Jul; 26(4):130-1. PubMed ID: 8234452
    [No Abstract]   [Full Text] [Related]  

  • 56. Serotonin function and mechanism of action of antidepressant treatment. Effects of amitriptyline and desipramine.
    Charney DS; Heninger GR; Sternberg DE
    Arch Gen Psychiatry; 1984 Apr; 41(4):359-65. PubMed ID: 6703855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac beta-adrenergic sensitivity in depression: relation with endogenous subtype and desipramine response.
    Bertschy G; Vandel S; Puech A; Vandel B; Sandoz M; Allers G
    Neuropsychobiology; 1989; 21(4):177-81. PubMed ID: 2561009
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Exploratory study of amitriptyline resistance in depressed patients: results of WHO French collaborating center on depressions resistant to treatments].
    Loas G; Rose D; Nowaczkowski P; Lernout P; Duron B
    Ann Med Psychol (Paris); 1996 Jun; 154(3):202-3. PubMed ID: 8766501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Noradrenergic dysfunction and antidepressant treatment response.
    Corrêa H; Duval F; Claude MM; Bailey P; Tremeau F; Diep TS; Crocq MA; Castro JO; Macher JP
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):163-8. PubMed ID: 11313162
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regional cerebral blood flow changes following chronic administration of antidepressant drugs.
    Passero S; Nardini M; Battistini N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):627-36. PubMed ID: 8588061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.